Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer

Near‐infrared (NIR) fluorescence optical imaging is a promising technique to assess the tumor margins during cancer surgery. This technique requires targeting by specific fluorescence agents to differentiate tumor from normal surrounding tissue. We assessed the feasibility of cancer detection using NIR fluorescence agents that target either αvβ3 integrins or the enhanced permeability and retention (EPR) effect in an orthotopic mouse model of oral cancer.

[1]  Peter Lassota,et al.  Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo , 2010, PloS one.

[2]  F. Watt,et al.  Changes in the expression of alpha v integrins in oral squamous cell carcinomas. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  Hiroshi Maeda,et al.  Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. , 2010, Bioconjugate chemistry.

[4]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[5]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[6]  R. Nason,et al.  The clinical significance of the positive surgical margin in oral cancer. , 2007, Oral oncology.

[7]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[9]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[10]  M. Hutteman,et al.  Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin α(v)β(3) expression in a syngeneic rat model. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  A. Beer,et al.  Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. , 2009, Frontiers in bioscience.

[12]  Greg M. Thurber,et al.  Detection limits of intraoperative near infrared imaging for tumor resection , 2010, Journal of surgical oncology.

[13]  H. Gremlich,et al.  Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation. , 2010, Bioconjugate chemistry.

[14]  Bohumil Bednar,et al.  Dual In Vivo Quantification of Integrin-targeted and Protease-activated Agents in Cancer Using Fluorescence Molecular Tomography (FMT) , 2010, Molecular Imaging and Biology.

[15]  C. O'brien,et al.  Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. , 2003, The British journal of oral & maxillofacial surgery.

[16]  H. Sterenborg,et al.  Image‐guided surgery in head and neck cancer: Current practice and future directions of optical imaging , 2012, Head & neck.

[17]  P. Slootweg,et al.  Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. , 2002, Oral oncology.

[18]  Sibylle Ziegler,et al.  Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .

[19]  Alexander L. Vahrmeijer,et al.  Optical Image-guided Surgery—Where Do We Stand? , 2010, Molecular Imaging and Biology.

[20]  M. Schwaiger,et al.  Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. , 2001, Cancer research.

[21]  T. Mikkelsen,et al.  Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Gilcrease,et al.  Integrin signaling in epithelial cells. , 2007, Cancer letters.

[23]  F. Watt,et al.  Changes in the expression of αv integrins in oral squamous cell carcinomas , 1997 .

[24]  Ge Zhou,et al.  The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue. , 2009, Archives of otolaryngology--head & neck surgery.

[25]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.